A Single-Arm, Phase II Clinical Trail of Cadonilimab Combined With Chemoradiotherapy in Oligometastatic Stage IVB Cervical Cancer

Clinical trial NCT06998394 · RECRUITING

Trial details

NCT number: NCT06998394
Sponsor: Xiangbo Wan
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer Stage IV

Start date: 2025-03-12
Primary completion: 2027-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.